Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon in PEI due to Chronic Pancreatitis or Pancreatectomy
NCT00414908Phase 3Completed
- Sponsor
- Solvay
- Start
- Oct 2007
- Primary completion
- Aug 2008
- Modality
- Replacement Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of pancrelipase in exocrine pancreatic insufficiency (EPI), sponsored by Solvay. Started Oct 2007; status: completed.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT00414908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414908.